Analytical Data Processing: Get to know the new Bruker Chemist Suite

Bruker Chemist Suite is a new software solution offered exclusively to Bruker customers. It contains a set of efficient tools for data management, processing, analysis and reporting of various analytical data (NMR, LC/GC/MS, UV-Vis, IR, Raman, Fluorescence). It also provides powerful modules for quantification and purity determination, for generating IUAPC name from chemical structure and for NMR spectra prediction. Bruker Chemist Suite is our new solution for confirmation of chemical structure identity and structure verification.

What to expect

This webinar will give you a sneak preview on the features that Bruker Chemist Suite is offering. You will get a general overview of the software (brief summary of the plugins that make up this package), as well as practical examples. The practical session will particularly focus on structure verification.

Who Should Attend?

Anybody who is interested in a software that can be used for a broad range of post-acquisition processing tasks of analytical data, such as processing, analysis, reporting, quantification and structure verification.  

Presenter: Jérôme Coutant (NMR Application Scientist at Bruker BioSpin and Product Manager of Structure Verification)

Jerome Coutant studied chemistry at undergraduate level and hold a PhD in NMR spectroscopy from Université Pierre et Marie Curie, working on structure determination of proteins and protein-protein complexes. He then joined Université d’Evry as post-doctoral researcher and used NMR to solve the structure of small and medium-sized peptides. He moved to Bruker in 2007 as an application scientist, with a focus on liquid state NMR for small molecules.

Presenter: Gary Sharman, PhD (Senior Scientific Director)

Gary studied Natural sciences at the University of Cambridge before completing a PhD with prof Dudley Williams on structural and mechanistic studies by NMR and MS. He spent 20 years in the pharmaceutical industry, working in analytical chemistry at AstraZeneca and Eli Lilly, where he developed a particular interest in data flows and visualisations. He moved to Mestrelab in 2020, where his role centres around automation, data processing and customisation.